Detection of p53 Gene Mutations in Human Brain Tumors by Single-strand Conformation Polymorphism Analysis of Polymerase Chain Reaction Products
- 1 January 1991
- book chapter
- Published by Springer Nature
- Vol. 6 (8) , 311-316
- https://doi.org/10.1007/978-4-431-68150-2_41
Abstract
The normal (wild-type) p53 product acts as a suppressor of transformation [1], while mutated p53 proteins may inactivate the wild-type p53 function resulting in cell transformation [2]. Mutations of the p53 gene have been found in conjunction with chromosome 17p allelic deletions in many human tumors [3,4]. Keywords Anaplastic Astrocytoma Sequence Alteration SSCP Analysis Include Point Mutation Asymmetric Polymerase Chain Reaction These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.Keywords
This publication has 12 references indexed in Scilit:
- p53 mutations in colorectal cancer.Proceedings of the National Academy of Sciences, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reactionGenomics, 1989
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989
- The p53 proto-oncogene can act as a suppressor of transformationCell, 1989
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.Proceedings of the National Academy of Sciences, 1989
- A variation in the structure of the protein-coding region of the human p53 geneGene, 1988
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA PolymeraseScience, 1988
- A general method for isolation of high molecular weight DNA from eukaryotesNucleic Acids Research, 1976